Last $12.72 USD
Change Today -0.15 / -1.17%
Volume 17.5K
SRNE On Other Exchanges
As of 10:04 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard G. Vincent CPA

Chief Financial Officer, Principal Accounting Officer and Executive Vice President, Sorrento Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

As of Fiscal Year 2013


Mr. Richard G. Vincent, CPA has been Chief Financial Officer of Sorrento Therapeutics, Inc. since February 2010 and serves as its Executive Vice President & Principal Accounting Officer. Since April 2008, Mr. Vincent has served as a contract Chief Financial Officer for various other companies, including Elevation Pharmaceuticals, Inc., Meritage Pharma, Inc., Genoa Pharmaceuticals, Inc., Chumby Industries, Inc. and Suneva Medical, Inc. Mr. Vincent co-founded Genoa Pharmaceuticals, ...

Read Full Background

Corporate Headquarters*

6042 Cornerstone Ct. West
San Diego, California 92121

United States

Phone: 858-210-3700
Fax: 858-210-3759

Board Members Memberships*

Chief Financial Officer, Principal Accounting Officer and Executive Vice President


San Diego State University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$296,007

Stock Options*

All Other Compensation$25,557
Exercisable Options121,313
Unexercisable Options98,687
Total Number of Options220,000

Total Compensation*

Total Annual Cash Compensation$321,564
Total Short Term Compensation$296,007
Other Long Term Compensation$25,557
Total Calculated Compensation$892,564
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SRNE:US $12.72 USD -0.15


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SORRENTO THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at